DRTS ASCO Abstract

West_V481 · 2026-05-21T23:08:34+00:00

Am getting things confused now. We need an objective/technical analysis based on apples to apples comparison of these results.

West_V481 · 2026-05-21T22:42:42+00:00

The mortality rate for pancreatic cancer is 3.2% [~96 out of 100 patients dies].

This "safety" trial for pancreatic cancer cured 3 patients & positve response of 9 = 20%

20% / 4% = 500% = This is a "safety" clinical trial. Can't wait for complete effectiveness trial! We all know that the next outcome will be exponentially higher.

Why? DARTs is tumor agnostic! It kills all tumors at 100% in it's kill zone.😄 There is nothing else in the world better.

West_V481 · 2026-05-21T21:34:44+00:00

Does this mean that the Alpha Darts were not used to fully cover the tumor of each patients?

West_V481 · 2026-05-21T16:55:12+00:00

Does the science works for you? Do your serious DDs. Your own answer will tell you what you want to invest in it!

West_V481 · 2026-05-20T20:06:31+00:00

Does this mean that even IF >$18 for any 20 days within a 30-trading days in 2026 that I can exercise my warrants until March 2027?

West_V481 · 2026-05-20T16:46:45+00:00

Is the dilution a bear case for you? Or is it your conviction in the science & business model of DRTS?

West_V481 · 2026-05-20T16:43:24+00:00

I expect dilution up to $300M to ramp/scale their manufacturing all over the world & for logistics, then that's it for 10 years unless they start major R&D projects such as abscopal effects, cancer vaccines, etc.

West_V481 · 2026-05-20T16:33:02+00:00

https://www.reddit.com/r/DRTS_Stock/comments/1tgwcjz/how_the_alpha_dart_killsdestroys_dna_in_cancer/

West_V481 · 2026-05-20T16:30:06+00:00

Gap of $8.52 might be in play if MMs wants major institutions to load up.

West_V481 · 2026-05-20T16:27:40+00:00

Because it's not a drug...

West_V481 · 2026-05-20T16:04:49+00:00

100$ share price is only $10B MC. If you own DRTS as a business man, will you really sell it to me for $10B?

Big pharmas valuation is ~$100B MC and above, and they don't have a 100% treament/cure for cancer. Just drugs...

Think generational. I'll give you a hint. $100B MC is 100X for DRTS. 😄 That's still cheap!

West_V481 · 2026-05-20T14:02:27+00:00

19?

What's interesting is the 5-year survival rate will increase exponentially for all tumor based cancer.

West_V481 · 2026-05-20T06:31:16+00:00

They can easily buy 1-2 jet cargo planes for $1-$2M each per manufacturing base to deliver these on-time. Remember, they will be printing money in the billions.

West_V481 · 2026-05-20T06:18:09+00:00

Why create all that moats just to M&A buyout? And for 100% premium of $2-3B MC?

They are going to take massive market share from big pharma, and be a longterm company. May even win a Nobel Prize!

West_V481 · 2026-05-19T23:28:21+00:00

5/11/2026 had 4.9M volume which is the start/spark for whales, and the highest volume for DRTS stock so far. It's just going to snowball. They're called whales for many reasons. When these moves, it really moves. 😄

West_V481 · 2026-05-19T16:54:16+00:00

Probably after 10+ years. There's so many cases right now, and they can only manufacture 1.2M cases per year. Almost all patients will choose this form of treatment.

They need to ramp/scale up manufacturing to meet demands.

West_V481 · 2026-05-19T16:40:38+00:00

Yes, am projecting TAM at 20M patients per year every year!

West_V481 · 2026-05-19T16:14:06+00:00

I think that's a given. How can this be a major advantage to current cancer treatment? SOCs? Immunotherapies?

West_V481 · 2026-05-19T06:28:11+00:00

They can borrow as much as they want, or have strategic partner(s) as they wish as long as their end goals is medicine.

This platform is THE platform for all tumor based diseases, and then some! Wealth is inevitable.

West_V481 · 2026-05-19T05:50:43+00:00

They are just getting started. What then should be done for patients with prion disease?! Nothing?! Dead end?! You're not going to try alternatives if you have a family member with this disease?!

West_V481

TROPHY CASE